Murray David Esler

Murray David Esler's AcademicInfluence.com Rankings

Murray David Esler

Philosophy

#3425

World Rank

#5546

Historical Rank

Logic

#1152

World Rank

#1827

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Murray David Esler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Murray David Esler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial (2010) (2086)
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study (2009) (1613)
Renal sympathetic-nerve ablation for uncontrolled hypertension. (2009) (754)
Adverse consequences of high sympathetic nervous activity in the failing human heart. (1995) (661)
Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. (1988) (638)
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension: A Pilot Study (2011) (582)
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study (2014) (577)
“Stress” and coronary heart disease: psychosocial risk factors (2003) (573)
Mild high-renin essential hypertension. Neurogenic human hypertension? (1977) (542)
Effect of sunlight and season on serotonin turnover in the brain (2002) (491)
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. (2015) (477)
Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation (2004) (455)
How to assess sympathetic activity in humans. (1999) (442)
Cardiac sympathetic nerve function in congestive heart failure. (1996) (439)
The human sympathetic nervous system: its relevance in hypertension and heart failure. (2012) (436)
The sympathetic system and hypertension. (2000) (428)
Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial (2012) (426)
Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy (2003) (421)
Heart Rate Spectral Analysis, Cardiac Norepinephrine Spillover, and Muscle Sympathetic Nerve Activity During Human Sympathetic Nervous Activation and Failure (1994) (415)
Sympathetic activation in chronic renal failure. (2009) (406)
Mechanisms of sympathetic activation in obesity-related hypertension. (2006) (401)
Translational medicine: the antihypertensive effect of renal denervation. (2010) (397)
Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. (1991) (396)
The sympathetic nervous system alterations in human hypertension. (2015) (393)
The sympathetic nervous system and the metabolic syndrome. (2007) (369)
Neural mechanisms in human obesity-related hypertension. (1999) (367)
Human ageing and the sympathoadrenal system (2000) (365)
Renal denervation in moderate to severe CKD. (2012) (360)
Determination of norepinephrine apparent release rate and clearance in humans. (1979) (357)
The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. (1986) (331)
Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension (2013) (327)
EFFECT OF CHANGING LEVELS OF PHYSICAL ACTIVITY ON BLOOD-PRESSURE AND HAEMODYNAMICS IN ESSENTIAL HYPERTENSION (1986) (312)
Sympathetic nervous system and insulin resistance: from obesity to diabetes. (2001) (309)
Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial (2012) (306)
Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. (1997) (302)
Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. (1994) (298)
Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. (1992) (294)
Autonomic nervous cardiovascular regulation in borderline hypertension. (1975) (294)
Measurement of total and organ-specific norepinephrine kinetics in humans. (1984) (293)
Adrenergic nervous system in heart failure. (1997) (289)
Interactions Between Leptin and the Human Sympathetic Nervous System (2003) (276)
Sympathetic Activity in Major Depressive Disorder: Identifying Those at Increased Cardiac Risk? (2007) (266)
Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension (2013) (257)
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? (2020) (252)
Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. (2009) (241)
The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. (2010) (240)
Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. (2001) (230)
Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. (2014) (230)
Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. (1999) (230)
Cardiac Sympathetic Nervous Activit in Congestive Heart Failure Evidence for Increased Neuronal Norepinephrine Release and Preserved Neuronal Uptake (1993) (230)
Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. (2005) (225)
Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. (2000) (219)
Change in Sympathetic Nerve Firing Pattern Associated with Dietary Weight Loss in the Metabolic Syndrome (2011) (206)
Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. (2001) (204)
Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. (2008) (200)
Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. (1998) (200)
Noradrenaline turnover during under- and over-eating in normal weight subjects. (1982) (196)
Exercise Training Lowers Resting Renal But Not Cardiac Sympathetic Activity in Humans (1991) (195)
The peripheral kinetics of norepinephrine in depressive illness. (1982) (195)
Sympathetic Nervous System Activity Is Associated With Obesity-Induced Subclinical Organ Damage in Young Adults (2010) (193)
Dysautonomias: Clinical Disorders of the Autonomic Nervous System (2002) (191)
Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. (1982) (190)
Losartan Increases Bradykinin Levels in Hypertensive Humans (2005) (187)
Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension (2007) (182)
In vivo measurement of neuronal uptake of norepinephrine in the human heart. (1988) (182)
Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics (2016) (173)
Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. (1995) (172)
Age-dependence of noradrenaline kinetics in normal subjects. (1981) (170)
Noradrenaline release and sympathetic nervous system activity. (1985) (165)
Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. (1993) (158)
Levels of anxiety in colonic disorders. (1973) (158)
Leptin is released from the human brain: influence of adiposity and gender. (1999) (155)
CHRONIC MENTAL STRESS IS A CAUSE OF ESSENTIAL HYPERTENSION: PRESENCE OF BIOLOGICAL MARKERS OF STRESS (2008) (154)
Aging effects on human sympathetic neuronal function. (1995) (153)
Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. (2003) (152)
Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. (2011) (150)
Raised Sympathetic Nerve Activity in Heart Failure and Central Sleep Apnea Is Due to Heart Failure Severity (2003) (148)
Renal denervation: a potential new treatment modality for polycystic ovary syndrome? (2011) (148)
Device-Based Antihypertensive Therapy: Therapeutic Modulation of the Autonomic Nervous System (2011) (145)
Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. (2013) (145)
Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. (2003) (144)
Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. (2012) (143)
Altered Cardiac Responsiveness and Regulation in the Normal Cardiac Output Type of Borderline Hypertension (1975) (141)
Sympathetic Nerve Biology In Essential Hypertension (2001) (139)
Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. (2014) (139)
Norepinephrine Kinetics in Essential Hypertension (1981) (139)
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. (2013) (138)
New drugs, procedures, and devices for hypertension (2012) (137)
Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. (1991) (136)
Sustained Sympathetic and Blood Pressure Reduction 1 Year After Renal Denervation in Patients With Resistant Hypertension (2014) (133)
Sympathetic Nervous Function in Human Heart as Assessed by Cardiac Spillovers of Dihydroxyphenylglycol and Norepinephrine (1992) (131)
Time-course of the antihypertensive and autonomic effects of regular endurance exercise in human subjects. (1990) (131)
Acute Effects of Continuous Positive Airway Pressure on Cardiac Sympathetic Tone in Congestive Heart Failure (2001) (131)
Contribution of individual organs to total noradrenaline release in humans. (1984) (130)
Reduced myocardial nerve growth factor expression in human and experimental heart failure. (2000) (125)
Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry (2016) (125)
Gender differences in sympathetic nervous activity: influence of body mass and blood pressure (2007) (122)
The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension (2011) (120)
Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. (2010) (119)
Effects of aging on epinephrine secretion and regional release of epinephrine from the human heart. (1995) (119)
Hydrocortisone‐Induced Hypertension in Humans: Pressor Responsiveness and Sympathetic Function (1989) (117)
Mediators of sympathetic activation in metabolic syndrome obesity (2008) (116)
Psychophysiological Mechanisms in Panic Disorder: A Correlative Analysis of Noradrenaline Spillover, Neuronal Noradrenaline Reuptake, Power Spectral Analysis of Heart Rate Variability, and Psychological Variables (2006) (115)
Increased suicide rate in the middle-aged and its association with hours of sunlight. (2003) (114)
Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. (1993) (111)
Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects (2009) (111)
Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension (1993) (111)
SUPPRESSION OF SYMPATHETIC NERVOUS FUNCTION IN LOW-RENIN ESSENTIAL HYPERTENSION (1976) (110)
Sympathetic neuronal regulation of the heart in aging and heart failure. (2005) (109)
Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings. (2014) (109)
Exercise and aging: autonomic control of the circulation. (1994) (108)
Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. (1992) (105)
Biochemical evidence of sympathetic hyperactivity in human hypertension. (1991) (104)
Measurement of Sympathetic Nervous System Activity in Heart Failure: The Role of Norepinephrine Kinetics (2000) (102)
Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. (1997) (102)
Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. (2009) (102)
Cardiac Sympathetic Dysautonomia in Chronic Orthostatic Intolerance Syndromes (2002) (101)
Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge (1989) (101)
Mental stress and human cardiovascular disease (2017) (101)
The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? (2019) (100)
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. (2005) (99)
The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. (2002) (98)
Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension. (1973) (98)
Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. (1991) (97)
The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. (2011) (97)
Phenotypic Evidence of Faulty Neuronal Norepinephrine Reuptake in Essential Hypertension (2000) (95)
Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure (2010) (94)
Effect of norepinephrine uptake blockers on norepinephrine kinetics (1981) (94)
Leptin in human plasma is derived in part from the brain, and cleared by the kidneys (1998) (92)
Regional sympathetic nervous activation after a large meal in humans. (1995) (91)
The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? (2001) (90)
The role of sympathetic nervous activity in renal injury and end-stage renal disease (2010) (90)
Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation (2004) (89)
Sympathetic Nervous System: Contribution to Human Hypertension and Related Cardiovascular Diseases (1995) (86)
Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. (1995) (86)
Health-Related Quality of Life After Renal Denervation in Patients With Treatment-Resistant Hypertension (2012) (86)
Evidence for increased renal norepinephrine overflow during sodium restriction in humans. (1990) (84)
Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. (1999) (84)
Relation of renin status to neurogenic vascular resistance in borderline hypertension. (1975) (83)
Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. (2010) (82)
Specific Serotonin Reuptake Inhibition in Major Depressive Disorder Adversely Affects Novel Markers of Cardiac Risk (2007) (81)
Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses. (1993) (81)
SYMPATHETIC TONE MODULATES PORTAL VENOUS PRESSURE IN ALCOHOLIC CIRRHOSIS (1986) (81)
Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans (2009) (80)
Altered Sympathetic Nervous Reactivity and Norepinephrine Transporter Expression in Patients With Postural Tachycardia Syndrome (2008) (78)
Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. (1993) (78)
Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. (2006) (78)
Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. (1998) (78)
Increased norepinephrine spillover into the jugular veins in essential hypertension. (1992) (78)
Persistence of muscle sympathetic nerve activity during vasovagal syncope. (2010) (77)
Renal nerve ablation reduces augmentation index in patients with resistant hypertension (2013) (77)
Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. (2001) (76)
Effects of Renal Denervation on Sympathetic Activation, Blood Pressure, and Glucose Metabolism in Patients with Resistant Hypertension (2012) (76)
Sympatholytic action of intravenous amiodarone in the rat heart. (1995) (76)
Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder. (2009) (76)
Plasma noradrenaline kinetics in humans. (1984) (76)
Plasma Norepinephrine Responses to Head‐Up Tilt Are Misleading in Autonomic Failure (1992) (75)
Role of the autonomic nervous system in mild human hypertension. (1975) (75)
Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure (2012) (75)
The neuronal noradrenaline transporter, anxiety and cardiovascular disease (2006) (75)
QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder. (2008) (73)
The ‘adrenaline hypothesis’ of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension (2000) (72)
Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol (1977) (72)
Autonomic Control of the Aging Heart (2008) (72)
Elevated total body noradrenaline spillover in normotensive members of hypertensive families. (1993) (70)
Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. (2004) (70)
Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond? (2014) (70)
Effect of propranolol on noradrenaline kinetics in patients with essential hypertension. (1981) (69)
Human Sympathetic Nerve Biology (2008) (69)
The neurobiology of human obesity (2005) (69)
Ghrelin Modulates Sympathetic Nervous System Activity and Stress Response in Lean and Overweight Men (2011) (69)
Total and renal sympathetic nervous system activity in alcoholic cirrhosis. (1985) (68)
Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness. (1973) (68)
Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS) (2014) (67)
Neuroadrenergic Dysfunction Along the Diabetes Continuum (2012) (65)
β-blockers, angiotensin II, and ACE inhibitors in patients with heart failure (2001) (64)
Renal denervation and hypertension. (2011) (64)
Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. (1976) (63)
Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism. (1999) (63)
Sympathetic responsiveness to head-up tilt in essential hypertension. (1973) (63)
Sympathetic and cardiac baroreflex function in panic disorder (2002) (62)
Kinins in humans. (2000) (61)
Regional epinephrine kinetics in human heart failure: evidence for extra-adrenal, nonneural release. (1995) (61)
Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. (1991) (61)
Panic disorder: coronary spasm as a basis for cardiac risk? (1998) (61)
Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. (2013) (61)
Differential effect of acute baroreceptor unloading on cardiac and systemic sympathetic tone in congestive heart failure. (1998) (61)
Neuronal Reuptake of Norepinephrine and Production of Dihydroxyphenyiglycol by Cardiac Sympathetic Nerves in the Anesthetized Dog (1991) (60)
Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans. (1998) (60)
393 NEUROADRENERGIC DYSFUNCTION ALONG THE DIABETIC CONTINUUM: A COMPARATIVE STUDY IN OBESE METABOLIC SYNDROME SUBJECTS (2012) (60)
Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering. (2015) (59)
Norepinephrine Turnover Is Increased in Suprabulbar Subcortical Brain Regions and Is Related to Whole-Body Sympathetic Activity in Human Heart Failure (2002) (59)
Total, and organ-specific, noradrenaline plasma kinetics in essential hypertension. (1984) (58)
Blunted norepinephrine responsiveness to changing energy states in obese subjects. (1985) (57)
Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension (2016) (55)
Renal denervation for treatment of drug-resistant hypertension. (2015) (55)
Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: Reduction by a selective serotonin reuptake inhibitor (2007) (55)
Norepinephrine spillover at rest and during submaximal exercise in young and old subjects. (1997) (55)
Relative Atrial Natriuretic Peptide Deficiency and Inadequate Renin and Angiotensin II Suppression in Obese Hypertensive Men (2013) (54)
Effects of estrogen and estrous cycle on glucocorticoid and catecholamine responses to stress in sheep. (1998) (54)
Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness (2007) (54)
Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome (2009) (54)
Recurrent Postural Vasovagal Syncope: Sympathetic Nervous System Phenotypes (2011) (53)
Leptin-Receptor Polymorphisms Relate to Obesity through Blunted Leptin-Mediated Sympathetic Nerve Activation in a Caucasian Male Population (2008) (53)
Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review. (2019) (53)
Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype. (2004) (53)
Renal Denervation Reduces Monocyte Activation and Monocyte–Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk (2017) (53)
Treatment of orthostatic hypotension with dihydroergotamine. (1979) (53)
Single‐unit analysis of sympathetic nervous discharges in patients with panic disorder (2006) (52)
Regional homovanillic acid production in humans. (1993) (52)
Cardiac Sympathetic Nerve Biology and Brain Monoamine Turnover in Panic Disorder (2004) (51)
Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence. (2019) (51)
Single‐unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover (2011) (51)
Simultaneous determination of plasma noradrenaline and adrenaline kinetics (1990) (51)
Low-Dose Estrogen Supplementation Improves Vascular Function in Hypogonadal Men (2001) (50)
Postprandial sympatho-adrenal activity: its relation to metabolic and cardiovascular events and to changes in meal frequency. (1995) (50)
Agreement among three different indices of sympathetic nervous system activity in essential hypertension. (1977) (50)
Direct Evidences for Sympathetic Hyperactivity and Baroreflex Impairment in Tako Tsubo Cardiopathy (2014) (50)
Renal Denervation in Human Hypertension: Mechanisms, Current Findings, and Future Prospects (2012) (49)
Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. (1995) (49)
Determinants of baroreflex sensitivity in man. (1978) (48)
Low oral bioavailability of dihydroergotamine and first‐pass extraction in patients with Orthostatic hypotension (1981) (48)
Epigenetic Modification of the Norepinephrine Transporter Gene in Postural Tachycardia Syndrome (2012) (47)
Differences in the neuronal removal of circulating epinephrine and norepinephrine. (1990) (46)
Sympathetic Nervous System Moves Toward Center Stage in Cardiovascular Medicine: From Thomas Willis to Resistant Hypertension (2014) (46)
Effect of renal denervation on kidney function in patients with chronic kidney disease. (2017) (46)
Postural syncope: mechanisms and management (2007) (46)
The Sympathetic Nervous System in Hypertension: Back to the Future? (2015) (45)
Regional 5-hydroxyindoleacetic acid production in humans. (1995) (44)
European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? (2010) (44)
The determinants of plasma-renin activity in essential hypertension. (1978) (43)
Circulatory regulation at rest and exercise and the functional assessment of patients with congestive heart failure. (1990) (42)
Effects of changes in physical activity on blood pressure and sympathetic tone. (1984) (42)
Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? (2018) (42)
Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion (2004) (42)
Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine beta-hydroxylase deficiency. (1995) (41)
Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release. (1984) (41)
European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. (2009) (41)
Simultaneous Characterization of Sympathetic and Cardiac Arms of the Baroreflex through Sequence Techniques during Incremental Head-Up Tilt (2016) (40)
Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects. (2012) (40)
Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S‐nitrosylation (2000) (40)
Biochemical quantification of sympathetic nervous activity in humans using radiotracer methodology: fallibility of plasma noradrenaline measurements. (1982) (38)
LONG-TERM FOLLOW-UP OF CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION CONFIRMS DURABLE BLOOD PRESSURE REDUCTION (2012) (38)
Immune response to a single bout of exercise in young and elderly subjects (1998) (37)
Renal denervation for hypertension: observations and predictions of a founder. (2014) (37)
SINGLE‐UNIT SYMPATHETIC DISCHARGE PATTERN IN PATHOLOGICAL CONDITIONS ASSOCIATED WITH ELEVATED CARDIOVASCULAR RISK (2008) (37)
Calibrated variability of muscle sympathetic nerve activity during graded head-up tilt in humans and its link with noradrenaline data and cardiovascular rhythms. (2016) (37)
Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study. (2017) (37)
Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. (1991) (36)
Monoaminergic neuronal activity in subcortical brain regions in essential hypertension. (1994) (36)
A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism (2017) (36)
Depression of efferent parasympathetic control of heart rate in rats with myocardial infarction: effect of losartan. (1998) (35)
Methylation of the SLC6a2 Gene Promoter in Major Depression and Panic Disorder (2013) (35)
Antiadrenergic effect of chronic amiodarone therapy in human heart failure. (1999) (35)
Radiotracer methodology for the simultaneous estimation of total, and renal, sympathetic nervous system activity in humans (1982) (35)
National Heart Foundation of Australia position statement update (2003) (35)
Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function. (2002) (34)
Neuronal re-uptake of noradrenaline by sympathetic nerves in humans. (1991) (34)
EFFECT OF PROLONGED TREATMENT ON HÆMODYNAMICS OF ESSENTIAL HYPERTENSION BEFORE AND AFTER AUTONOMIC BLOCK (1980) (34)
Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure (1991) (33)
Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. (1998) (33)
Externally Delivered Focused Ultrasound for Renal Denervation. (2016) (33)
Influence of ageing on the sympathetic nervous system and adrenal medulla at rest and during stress (2004) (32)
Control of the forearm microcirculation: interactions with measures of obesity and noradrenaline kinetics. (1998) (32)
Cerebral noradrenaline spillover and its relation to muscle sympathetic nervous activity in healthy human subjects. (1997) (31)
Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation. (2013) (31)
Heart and mind: psychogenic cardiovascular disease. (2009) (31)
Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. (2007) (31)
Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension (2012) (31)
Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation. (2014) (30)
Arterial compliance in hypertension. (1976) (30)
Effect of practolol on blood pressure and renin release in man (1974) (30)
Patterns of Catecholamine Excretion in Urine in Hypertension (1970) (30)
Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation. (1995) (29)
Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis. (2013) (29)
Mental stress is a cause of cardiovascular diseases: from scepticism to certainty (2008) (29)
Influence of leptin on neurotransmitter overflow from the rat brain in vitro (2002) (29)
beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure. (2001) (28)
Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension. (1980) (28)
A Comparative Study in Obese Metabolic Syndrome (2012) (28)
Fallibility of plasma noradrenaline measurements in studying postprandial sympathetic nervous responses. (1995) (28)
The autonomic nervous system and cardiac arrhythmias (1992) (26)
TCT-12 Long-term Follow-up of Catheter-based Renal Denervation For Resistant Hypertension Confirms Durable Blood Pressure Reduction (2012) (26)
Increased central blood volume: a poosible pathophysiological factor im mild low-renin essential hypertension. (1976) (26)
Neural mechanisms and management of obesity-related hypertension (2008) (25)
Angiotensin II and norepinephrine release: interaction and effects on the heart (2005) (25)
Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea) (2016) (25)
Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension. (1980) (24)
NET silencing by let-7i in postural tachycardia syndrome. (2017) (24)
Sympathetic activation in congestive heart failure: an updated overview (2019) (24)
Regional Sympathetic Effects of Low-Dose Clonidine in Heart Failure (2003) (24)
Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt (2011) (24)
Renal denervation: current implications and future perspectives. (2014) (23)
Ambulatory arterial stiffness index as a predictor of blood pressure response to renal denervation* (2018) (23)
Sympathetic nervous activation in essential hypertension: commonly neglected as a therapeutic target, usually ignored as a drug side effect. (2010) (23)
The effects of dietary weight loss on indices of norepinephrine turnover: Modulatory influence of hyperinsulinemia (2014) (23)
Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension. (2016) (23)
Measurement of human sympathetic nervous responses to stressors by microneurography. (1994) (23)
Selective vs. Global Renal Denervation: a Case for Less Is More (2018) (22)
Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs (1992) (22)
The future of renal denervation (2017) (21)
Stress reactivity and its association with increased cardiovascular risk: a role for the sympathetic nervous system? (2010) (21)
Contribution of cardiovascular reflexes to differences in beta-adrenoceptor-mediated responses in essential hypertension. (1981) (21)
Redevelopment of essential hypertension after cessation of long term therapy; preliminary findings. (1984) (21)
Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. (1991) (21)
Evaluation of elevated heart rate as a sympathetic nervous system biomarker in essential hypertension. (2020) (21)
Release of noradrenaline into the cerebrovascular circulation in patients with primary hypertension (1988) (21)
Mechanisms of Carvedilol Action in Human Congestive Heart Failure (2001) (21)
The sympathetic nervous system in renovascular hypertension: lead actor or 'bit' player? (2002) (21)
Modulation of renal sympathetic innervation: recent insights beyond blood pressure control (2018) (21)
Catheter-based renal denervation: the next chapter begins. (2018) (20)
High catecholamine essential hypertension: clinical and physiological characteristics. (1973) (20)
Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension. (1997) (20)
Norepinephrine Kinetics in Patients with Idiopathic Autonomic Insufficiency (1980) (20)
Protection of neuronal uptake-1 inhibitors in ischemic and anoxic hearts by norepinephrine-dependent and -independent mechanisms. (1998) (20)
Effects of Moxonidine and Low‐Calorie Diet: Cardiometabolic Benefits from Combination of Both Therapies (2017) (19)
SPRINT, or False Start, Toward a Lower Universal Treated Blood Pressure Target in Hypertension. (2016) (19)
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022) (19)
NPY and NPY Y1 receptor effects on noradrenaline overflow from the rat brain in vitro (2004) (19)
Cardiac secretion and renal clearance of atrial natriuretic peptide in normal man: effect of salt restriction. (1989) (19)
Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans. (1998) (19)
Obesity-Associated Organ Damage and Sympathetic Nervous Activity: A Target for Treatment? (2019) (18)
Association of vitamin D status and blood pressure response after renal denervation (2013) (18)
Human muscle sympathetic activity and cardiac catecholamine spillover: no support for augmented sympathetic noradrenaline release by adrenaline co-transmission. (1998) (18)
Effects of estrogen on stress responses in women. (1999) (18)
Altered venous responses to vasoconstrictor agonists and nerve stimulation in human primary hypertension. (1990) (18)
Catecholamines and essential hypertension. (1993) (18)
Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension (2001) (18)
Renal sympathetic denervation restores aortic distensibility in patients with resistant hypertension: data from a multi-center trial (2018) (18)
Anxiety - bridging the heart/mind divide (2010) (17)
Noradrenaline reuptake and plasma dihydroxyphenylglycol during sustained changes in sympathetic activity in rabbits. (1991) (17)
MENTAL STRESS, PANIC DISORDER AND THE HEART (1998) (17)
Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover. (1999) (17)
The effect of renal denervation on endothelial function and inflammatory markers in patients with resistant hypertension. (2015) (16)
Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure. (2003) (16)
Atrial Fibrillation Is Associated with Decreased Cardiac Sympathetic Response to Isometric Exercise in CHF in Comparison to Sinus Rhythm (2008) (16)
Increased spillover and reduced clearance both contribute to rise in plasma catecholamines after birth in lambs. (1996) (16)
The nervous system in arterial hypertension : [proceedings] (1976) (16)
Total body catecholamine kinetics before and after birth in spontaneously hypoxemic fetal lambs. (1999) (16)
Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits (1990) (16)
Last Word on Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension (2010) (16)
High-renin essential hypertension: adrenergic cardiovascular correlates. (1976) (16)
The cardiovascular amplifiers in human primary hypertension and their role in a strategy for detecting the underlying causes. (1987) (16)
Is essential hypertension sometimes a psychosomatic disorder? (2004) (16)
Renal denervation: Not as easy as it looks (2015) (15)
A polymorphism in the noradrenaline transporter gene is associated with increased blood pressure in patients with resistant hypertension (2017) (15)
Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline. (1995) (15)
Assessing the strength of cardiac and sympathetic baroreflex controls via transfer entropy during orthostatic challenge (2017) (15)
New Drugs and Technologies Device-Based Antihypertensive Therapy Therapeutic Modulation of the Autonomic Nervous System (2011) (15)
Atrial fibrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure. (2005) (15)
Divergent effects of ANP and BNP in acute heart failure: evidence for a putative BNP-selective receptor? (2002) (14)
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial (2022) (14)
Blood pressure and sympathetic nervous system response to renal denervation. (2013) (14)
How hypertension redevelops after cessation of long-term therapy. (1984) (14)
TCT-61 Optimized External Focused Ultrasound for Renal Sympathetic Denervation - Wave II trial (2013) (14)
Renal catecholamine metabolism. (1989) (14)
Pulmonary clearance and release of norepinephrine and epinephrine in newborn lambs. (1997) (14)
Role of Ca2+ in metabolic inhibition-induced norepinephrine release in rat brain synaptosomes. (1997) (13)
The failing human heart does not release nitrogen oxides. (1998) (13)
The relation of human cardiac sympathetic nervous activity to left ventricular mass: commentary. (1996) (13)
Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs. (1992) (13)
Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension. (1977) (13)
Characterization of the Asymmetry of the Cardiac and Sympathetic Arms of the Baroreflex From Spontaneous Variability During Incremental Head-Up Tilt (2019) (13)
The Sympathetic Nervous System in Cirrhosis (2007) (13)
Successful Renal Denervation Decreases the Platelet Activation Status in Hypertensive Patients. (2019) (13)
Greater sympathoadrenal activation with longer preventilation intervals after immediate cord clamping increases hemodynamic lability at birth in preterm lambs. (2017) (13)
Potential role of endurance training in altering renal sympathetic nerve activity in CKD? (2017) (13)
Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover (1999) (13)
Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity? (2006) (13)
ASSESSMENT OF NEURONAL UPTAKE OF NORADRENALINE IN HUMANS: DEFECTIVE UPTAKE IN SOME PATIENTS WITH ESSENTIAL HYPERTENSION (1980) (12)
TWO-YEAR DURABILITY OF BLOOD PRESSURE REDUCTION WITH CATHETER-BASED RENAL SYMPATHETIC DENERVATION: HT.3.04 (2010) (12)
Aromatase inhibition alters vascular reactivity and arterial compliance in men: a possible vascular role for endogenous sex hormones in males. (1999) (12)
ADRENALINE RELEASE BY THE HUMAN HEART (1991) (12)
Effects of weight loss on renal function in overweight Japanese men (2011) (12)
CENTRAL AND PERIPHERAL SYMPATHETIC ACTIVATION IN HEART FAILURE. (2021) (12)
Effects of estrogen and estrous cycle on glucocorticoid and catecholamine responses to stress in sheep. (1998) (12)
Mineralocorticoid induced hypertension and noradrenaline spillover in man. (1994) (11)
Recent advances in the treatment of hypertension (2011) (11)
Modulation of vascular function by diet and exercise. (1997) (11)
Effects of renal denervation on insulin resistance (2012) (11)
Renal Denervation-Ready for Prime Time!? The Steep SPYRAL Stairs to RADIANCE in Hypertension Treatment. (2018) (11)
Catechol‐O‐methyltransferase activity in CHO cells expressing norepinephrine transporter (1999) (11)
Stress and cardiovascular disease: a report from the National Heart Foundation of Australia (1988) (11)
Non-invasive evaluation of the cardiac function in Golden Retriever dogs by radionuclide angiography (1993) (11)
Brain derived neurotrophic factor (BDNF) release from the human brain in patients with type 2 diabetes—possible influence of venous anatomy and comorbid major depressive disorder (2007) (11)
The place of exercise in the long-term treatment of hypertension. (1987) (11)
Study of noradrenaline uptake and spillover to plasma in normal subjects and patients with essential hypertension. (1980) (11)
Central Nervous System Norepinephrine Turnover in Essential Hypertension fn1 (1995) (11)
Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion. (1977) (10)
Oxygen consumption in the heart, hepatomesenteric bed, and brain in young and elderly human subjects, and accompanying sympathetic nervous activity. (1996) (10)
The sympathetic regulation of the heart. (2016) (10)
New Therapeutic Approaches to Resistant Hypertension (2010) (10)
Cerebral metabolism and its relationship with sympathetic nervous activity in essential hypertension: evaluation of the Dickinson hypothesis (1996) (10)
Health-related quality of life and blood pressure 12 months after renal denervation (2015) (9)
Is adrenaline released by sympathetic nerves in man? (1991) (9)
Take a blood pressure pill or undergo renal denervation? (2018) (9)
Central nervous system noradrenergic and dopaminergic turnover in response to acute neuroleptic challenge. (1995) (9)
Neurogenic maintenance of peripheral resistance in borderline hypertension. (1974) (9)
High blood pressure management: potential benefits of I1 agents. (1998) (9)
Effects of Renal Denervation on Renal Artery Function in Humans: Preliminary Study (2016) (9)
Left ventricular norepinephrine and epinephrine kinetics at birth in lambs. (1997) (8)
The influence of aging on the plasma concentration and renal clearance of homovanillic acid (1994) (8)
Pathogenesis of human primary hypertension: a new approach to the identification of causal factors and to therapy. (1986) (8)
DIFFERING NORADRENALINE KINETICS IN ESSENTIAL HYPERTENSION AND DEPRESSIVE ILLNESS, TWO DISEASES IN WHICH THE PLASMA CONCENTRATION OF NORADRENALINE IS SOMETIMES ELEVATED (1981) (8)
Renal nerve ablation reduces blood pressure in a patient with renovascular hypertension resistant to drug and revascularisation therapies. (2012) (8)
Epigenomic changes associated with impaired norepinephrine transporter function in postural tachycardia syndrome (2017) (8)
Depressive illness, the sympathetic nervous system and cardiac risk. (2009) (8)
Cardiac ablation and renal denervation systems have distinct purposes and different technical requirements. (2013) (8)
Reduced HRV and baroreflex sensitivity as universally applicable cardiovascular “risk factors”: waiting for the bubble to burst (2003) (7)
The Effect of Renal Denervation on Plasma Adipokine Profile in Patients with Treatment Resistant Hypertension (2017) (7)
Effects of Nebivolol on Haemodynamics, Cardiac Dimensions and Function, Cardiovascular Reflexes and Biochemical Measures of Sympathetic Activity in Normal Human Subjects (1991) (7)
How can we measure sympathetic nervous system "tone" in patients? (1984) (7)
Relationship between Maximum Chronotropic Response to Isoproterenol in Man and Generation of Cyclic Adenosine Monophosphate by Lymphocytes (1980) (7)
Relationship between regression of cardiovascular hypertrophy and rate of redevelopment of hypertension. (1987) (7)
Factors influencing the choice of antihypertensive agents. (1976) (7)
CrossTalk opposing view: Which technique for controlling resistant hypertension? Renal nerve ablation (2014) (7)
Sympathetic nervous system neuroplasticity. (2006) (7)
[Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion]. (2003) (7)
Development of the metabolic syndrome along the female biological life-path. (2006) (7)
On a low calorie diet, are there separate and discrete effects of negative energy balance and weight loss on blood pressure? (2003) (7)
Consequences of the evolutionary cardiovascular challenge of human bipedalism: orthostatic intolerance syndromes, orthostatic hypertension. (2019) (6)
Does sympathetic dysfunction occur before denervation in pure autonomic failure? (2018) (6)
Renal denervation for resistant hypertension—the Symplicity HTN-1 study – Authors' reply (2014) (6)
Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients (2022) (6)
Catecholamine levels in tricyclic antidepressant self-poisoning. (1974) (6)
RATE OF REMOVAL OF NOREPINEPHRINE FROM THE CIRCULATION IN HEALTHY MEN AND PATIENTS WITH ESSENTIAL HYPERTENSION (1979) (6)
Management of Hypertension Complicated by Psychiatric Comorbidity (2007) (6)
Letter by Kaye and Esler regarding article "extracardiac progenitor cells repopulate most major cell types in the transplanted human heart". (2006) (6)
The sympathetic system in essential hypertension. (2000) (6)
An explanation of the unexpected efficacy of L-DOPS in pure autonomic failure (2004) (6)
Is very high sympathetic tone in heart failure a result of keeping bad company? (2003) (6)
Stress, behavior and the heart (2017) (5)
Renal Denervation After the SPYRAL HTN-OFF MED Trial: Putting a Complex Study Into Context. (2017) (5)
Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervation (2017) (5)
Predictive factors for successful renal denervation: should we use them in clinical trials? (2017) (5)
Effect of 1 year's therapy in essential hypertension on systemic haemodynamics studied before and after 'total' autonomic blockade. (1979) (5)
Impaired pancreatic polypeptide release to insulin hypoglycaemia in chronic autonomic failure with postural hypotension: evidence for parasympathetic dysfunction. (1982) (5)
Mental stress and human cardiovascular disease (2015) (5)
Acute mental stress responses : neural mechanisms of adverse cardiac consequences (2008) (5)
Sympathotonia in primary hypertension and in a caricature resembling dysautonomia. (1976) (5)
Does increased 24-h ambulatory heart rate identify de facto neurogenic hypertension, and facilitate selection of hypertensive patients for renal denervation? (2019) (5)
REDUCED BLOOD PRESSURE LOWERING EFFECT OF CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION: DATA FROM POOLED SYMPLICITY HTN TRIALS (2015) (5)
TCT-58 Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial (2013) (5)
[Sympathetic nerve activity in essential hypertension. New pathophysiologic aspects]. (2003) (4)
EFFICACY AND CLINICAL AND ECONOMIC EFFECTIVENESS IN RESISTANT HYPERTENSIVE SUBGROUPS (2012) (4)
Plasma lipocalin-2/NGAL is stable over 12 weeks and is not modulated by exercise or dieting (2021) (4)
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines. (2022) (4)
Sympathetic Activation in Essential Hypertension: Understanding the Toxic Trifecta. (2018) (4)
Central nervous system norepinephrine turnover in essential hypertension. (1995) (4)
Oestrogen supplementation attenuates responses to psychological stress in elderly men rendered hypogonadal after treatment for prostate cancer (2002) (4)
Central and peripheral norepinephrine kinetics in heart failure, coronary artery disease, and hypertension. (1998) (4)
Contribution of lungs to desipramine-induced changes in whole body catecholamine kinetics in newborn lambs. (1999) (4)
Abnormalities of the Autonomic Nervous System in Heart Failure: Assessment, Potential Mechanisms, and Implications (1995) (3)
ESSENTIAL HYPERTENSION WITH SYMPTOMS OF HYPERKINETIC CIRCULATION (1973) (3)
Renal artery denervation via catheter-based delivery of low-power radiofrequency energy provides safe and durable blood pressure reduction: complete 3 year results from SYMPLICITY HTN-1 (2013) (3)
A new approach to the identification of pathogenetic factors and to therapy in human primary hypertension. (1987) (3)
The Role of Cardiovascular Hypertrophy in Hypertension: Basis for a New Therapeutic Strategy (1987) (3)
Differential sympathetic response to lesion-induced chronic kidney disease in rabbits. (2020) (3)
Presynaptic antisympathetic action of amiodarone and its metabolite desethylamiodarone. (1999) (3)
Treatment of essential hypertension. (1979) (3)
EFFECT OF A SINGLE BOUT OF EXERCISE ON IMMUNE FUNCTION IN YOUNG AND ELDERLY SUBJECTS 555 (1996) (3)
Effect of endurance exercise on cardiac secretion and renal clearance of atrial natriuretic peptide in normal humans. (1990) (3)
Autonomic Nervous System: Metabolic Function (2009) (3)
Renal denervation reduces left ventricular mass in patients with resistant hypertension - results from a multicenter CMR-study (2013) (3)
Renal sympathetic denervation for refractory hypertension – Author's reply (2011) (2)
Catecholamine metabolites in internal jugular plasma: a window into the human brain. (1998) (2)
Methylation of the SLC 6 a 2 Gene Promoter in Major Depression and Panic Disorder (2017) (2)
Renal nerve ablation for hypertension: Update from an insider. (2018) (2)
EFFECTS OF INTRACELLULAR Ca2+ CHELATING ON NORADRENALINE RELEASE IN NORMOXIC AND ANOXIC HEARTS (1997) (2)
Cardiovascular and Autonomic Responses to Stress (2011) (2)
311 FEASIBILITY OF CATHETER-BASED RENAL DENERVATION AND EFFECTS ON SYMPATHETIC NERVE ACTIVITY AND BLOOD PRESSURE IN PATIENTS WITH END-STAGE RENAL DISEASE (2012) (2)
Dissociation of the renin lowering and antihypertensive actions of propranolol. (1976) (2)
Response to quality of life after renal denervation. (2013) (2)
Dyslipoproteinemia in North America: The Lipid Research Clinics Program Prevalence Study. (1986) (2)
Abstract 816: Sympathetic Nerve Protein Analysis, Sympathetic Microneurography and Catecholamine Kinetics in Postural Syncope Phenotypes (2007) (2)
Patterns of neurogenic involvement in borderline and essential hypertension. (1977) (2)
OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION (2016) (2)
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified (2022) (2)
Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension". (2014) (2)
EVIDENCE FOR A ROLE FOR THE CARDIOVASCULAR AMPLIFIERS IN HUMAN PRIMARY HYPERTENSION (1991) (2)
Letter by Schlaich et al regarding article, "Relationship between central sympathetic drive and magnetic resonance imaging determined left ventricular mass in essential hypertension". (2007) (2)
Sympathomodulation in congestive heart failure: From drugs to devices. (2020) (2)
Pseudopheochromocytoma. (2019) (2)
Effects of Dietary Sodium Intake on Indices of Sympathetic Activity in Normal Man (1980) (2)
SUSTAINED REDUCTION OF CENTRAL SYMPATHETIC OUTFLOW AFTER RENAL DENERVATION IN END STAGE RENAL DISEASE: 7B.10 (2011) (2)
Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. (2016) (2)
Results from a multicenter CMR-study in patients with resistant hypertension - pre and post renal denervation (2013) (2)
Cardiovascular trophic effects from the sympathetic nerve cotransmitter neuropeptide Y in end-stage renal disease? (2003) (2)
787 EFFECTS OF TRANSCATHETER RENAL NERVE ABLATION ON SYMPATHETIC AND NEUROHORMONAL ACTIVITY IN PATIENTS WITH RESISTANT HYPERTENSION (2012) (2)
Pivotal role of the sympathetic nerves of the human heart in mental stress responses and triggered cardiovascular catastrophes (2021) (2)
Neurochemical quantification of human organ-specific sympathetic nervous system activity. (2000) (2)
Harnessing the Autonomic Nervous System for Therapeutic Intervention (2012) (2)
Sympathetic Neurobiology of Orthostatic Intolerance: A systematic Biochemical and Molecular Analysis of Patients with Vasovagal Syncope, Low Supine Systolic Blood Pressure and Postural Tachycardia Syndrome (2008) (2)
Targeting Treatment Refractory NET by EZH2 Inhibition in Postural Tachycardia Syndrome. (2020) (2)
The adrenal medulla in cardiovascular medicine: an untold story (2020) (2)
PREDICTORS OF BLOOD PRESSURE RESPONSE FOLLOWING CATHETER RENAL DENERVATION: A POOLED ANALYSIS OF THE SYMPLICITY HTN-1AND HTN-2 TRIALS (2013) (1)
Expression of leptin and leptin receptor isoforms in human myocardium: A role in cardiac function and the pathophysiology of CHF? (2000) (1)
Abstract 18179: Catheter-Based Renal Denervation Reduces Left Ventricular Mass in Patients with Resistant Hypertension - Results from a Multicenter Study (2012) (1)
Measurement of Noradrenaline and Serotonin Metabolites With Internal Jugular Vein Sampling: An Indicator of Brain Monoamine Turnover in Depressive Illness and Panic Disorder (2022) (1)
ISH NIA OS-01 THE microRNA miR-19a-3p BINDS TO A POLYMORPHISM IN THE GENE FOR THE NORADRENALINE TRANSPORTER AND MAY INCREASE THE RISK OF CARDIOVASCULAR AND PSYCHIATRIC DISEASE. (2016) (1)
Two patients with abnormalities of regional sympathetic nervous tone. (1984) (1)
Practolol in hypertension: reduction in sympathetic nervous and renin responses. (1973) (1)
Renal denervation alters ambulatory blood pressure-derived salt sensitivity index in patients with uncontrolled hypertension (2021) (1)
ANESTHESIOLOGIST INTERVENTION RATE AND EFFICACY OF PARTURIENT‐CONTROLLED EPIDURAL ANALGESIA (PCEA) ‐ EFFECT OF INCREASING CONCENTRATION OF BOLUS SOLUTION USING 0.0625% BUPIVACAINE + 0.0002% FENTANYL BACKGROUND INFUSION: P‐59 (2002) (1)
Failure Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart (2000) (1)
[OP.7A.11] CHROMOGRANIN A AS A PREDICTIVE MARKER OF SUCCESSFUL RENAL DENERVATION (2017) (1)
Activity of the sympathetic nervous system and renin-angiotensin system in essential hypertension (1972) (1)
Assessing Correlation between Heart Rate Variability Markers Based on Laguerre Expansion and Direct Measures of Sympathetic Activity during Incremental Head-up Tilt (2021) (1)
CRT-608 Pooled 3-Year Symplicity Htn-1 and Symplicity Htn-2 Results and Diabetes Subgroup Analysis (2014) (1)
Clinical Studies of the Sympathetic Nervous System (2002) (1)
Estrogen supplementation decreases total body norepinephrine spillover in perimenopausal women (1996) (1)
Relationship of renin status to adrenergic vascular tone in borderline hypertension (1974) (1)
Reply: Platelet noradrenaline uptake is unrelated to renal denervation (2016) (1)
Response by Grassi et al to Letter Regarding Article, "The Sympathetic Nervous System Alterations in Human Hypertension". (2016) (1)
Reply: Possible impact of membrane ACE2 expression on COVID-19 infection. (2020) (1)
Response to Letter Regarding Article, “Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension: A Pilot Study” (2011) (1)
Norepinephrine transporter expression is inversely associated with glycaemic indices: a pilot study in metabolically diverse persons with overweight and obesity (2016) (1)
Potentiated Blood Pressure Response to Renal Nerve Ablation in Patients with Resistant Hypertension Treated with the Centrally Acting Sympatholytic Agent Moxonidine (2013) (1)
Wednesday, May 16, 4:00 PM to 6:00 PM Sympathetic Nervous System, I1 Imidazoline Receptors, Hypertension and Metabolic Disorders*: Sympathetic nervous system and insulin resistance: From obesity to diabetes* (2001) (1)
Droxidopa improves orthostatic intolerance symptoms in low and normal supine blood pressure phenotypes of vasovagal syncope (2015) (1)
[PP.05.32] PROFOUND SYMPATHETIC NERVOUS SYSTEM ACTIVATION IN PATIENTS WTH RESISTANT HYPERTENSION (2017) (1)
Response to letter regarding article, "renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?". (2014) (1)
Psychological Stress and the Development of Heart Disease (2007) (1)
The sympathetic nervous system through the ages: From Thomas Willis to resistant hypertension - The Physiological Society 2010 Paton Prize Lecture (2010) (1)
Role of the sympathetic nervous system in cardiometabolic control: implications for targeted multiorgan neuromodulation approaches (2021) (1)
The Causal Role of Chronic Mental Stress in the Pathogenesis of Essential Hypertension (2011) (1)
Neurovascular Role of Sympathetic Nervous System and Beta-Adrenoceptor Polymorphisms in Obesity and Hypertension (2008) (1)
Renal Denervation for the Hypertension of Chronic Kidney Disease: A Special Case? (2016) (1)
Sympathetic nervous activity and the thermic effect of food in humans. (1998) (1)
106 – Panic Disorder (2004) (1)
Chapter 126 – Panic Disorder (2012) (1)
Catheter based radiofrequency ablation of renal nerves for the treatment of resistant hypertension (2012) (1)
OS 19-01 BLOOD PRESSURE INDEPENDENT EFFECTS OF RENAL DENERVATION ON THE DECLINE OF KIDNEY FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. (2016) (1)
RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF DRUG-RESISTANT HYPERTENSION IN AN ASIAN POPULATION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY IN SOUTH KOREA (GSR KOREA) AND COMPARISON TO SYMPLICITY HTN-2 (2015) (0)
An evaluation of expectancy bias in interoceptive accuracy research (2006) (0)
A-33 | Clinical Event Reductions in Younger Vs. OLDER Hypertension Patients treated with Radiofrequency Renal Denervation: 10-Year Projections based on 3-Year Follow-up from the Global SYMPLICITY Registry (2022) (0)
The left vent ‘amplifier’ in hypertension (1986) (0)
A2589 Testing for achieved renal denervation in resistant hypertension patients by measuring passage of tyrosine hydroxylase from degraded sympathetic nerves to urine: Preliminary observations (2018) (0)
Reflections on the past four decades of mental stress research in autonomic cardiology (2021) (0)
EXOGENOUS BRAIN NATRIURETIC PEPTIDE INHIBITS REFLEX SYSTEMIC AND REGIONAL SYMPATHETIC STIMULATION IN HEALTHY HUMANS: P2.177 (2000) (0)
nervous activation in human obesity? Is obstructive sleep apnea the cause of sympathetic (2013) (0)
ELEVATED SYMPATHETIC NERVOUS ACTIVITY IS RELATED TO THE DEVELOPMENT OF RENAL INJURY IN PATIENTS WITH DIABETES AND/OR HYPERTENSION: PP.30.189 (2010) (0)
PP.40.06: RENAL ARTERY ANATOMY AFFECTS THE BLOOD PRESSURE RESPONSE TO RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION (2015) (0)
Atrial fibrillation further impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure (2005) (0)
Reply to letter to the Editor entitled: Ambulatory arterial stiffness index: a (too) easy predictor for renal denervation success? (2018) (0)
SIGNIFICANT, LONG–TERM REDUCTIONS IN BLOOD PRESSURE AND PULSE PRESSURE ARE OBSERVED IN BOTH OLDER AND YOUNGER PATIENTS WITH RESISTANT HYPERTENSION FOLLOWING TREATMENT WITH THE SYMPLICITY™ RENAL DENERVATION SYSTEM (2013) (0)
Panic disorder : sympathetic nervous mechanisms and net gene epigenetics underlying increased cardiac risk (2005) (0)
Transcatheter Aortic Valve Implantation Reduces Sympathetic Activity and Normalizes Arterial Spontaneous Barore ﬂ ex in Patients With Aortic Stenosis (2013) (0)
Sympathetic Neural and Adrenal Medullary Mechanisms in Depression and Panic Disorder (2011) (0)
Rest and Exercise and the Functional Assessment of Patients With Congestive Heart Failure (2005) (0)
Hearts and minds. (2003) (0)
Major lung contribution to despiramine - induced changes in whole body noradrenaline and adrenaline kinetics (1998) (0)
Assessing the Assessment of Brain Serotonin Turnover—Reply (2008) (0)
CARDIAC NORADRENALINE SPILLOVER IS NOT CORRELATED WITH HRV AND QT VARIABILITY IN PATIENTS WITH DEPRESSION AND PANIC DISORDER (2010) (0)
Asymmetry Assessment of Cardiac and Sympathetic Arms of the Baroreflex (2018) (0)
Rebuttal from Markus P. Schlaich, Yusuke Sata and Murray D. Esler (2014) (0)
CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY (2022) (0)
Season as a Possible Confounding Factor in Reduced Brain Serotonin Turnover Following Selective Serotonin Reuptake (2016) (0)
TCT-215 Effect Of Renal Denervation Therapy On Blood Pressure And Pulse Pressure In Young Compared To Old Patients (2012) (0)
Are Important Components of Kidney Function Lost With Renal Denervation? (2017) (0)
Ambulatory blood pressure changes and predictors of response in patients undergoing renal sympathetic denervation (2013) (0)
Re: Cardiac denervation does/does not play a major role in exercise limitation after heart transplantation. (2008) (0)
Renal denervation for severe hypertension: Past, present and future (2015) (0)
Response to four comments on ‘Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?’ (2020) (0)
CONTRIBUTION OF SYMPATHETIC NERVOUS SYSTEM ACTIVITY TO OBESITY–INDUCED SUBCLINICAL ORGAN DAMAGE IN YOUNG ADULTS: 9B.07 (2010) (0)
Cardiac Sympathetic Activity with Ageing and Relationship to Diastolic Function (1997) (0)
Psychogenic Cardiovascular Disease: Underlying Autonomic Nervous Mechanisms (2007) (0)
C-002 SYMPATHETIC NERVE PROTEIN ABNORMALITIES IN PATIENTS WITH RECURRENT VASOVAGAL SYNCOPE (2011) (0)
Ablating the renal nerves to treat heart failure with reduced ejection fraction: another treatment option in a crowded space? (2020) (0)
HUMAN OBESITY‐RELATED HYPERTENSION: BRAIN NEUROTRANSMITTERS AND REGIONAL NORADRENALINE SPILLOVER (1997) (0)
Biventricular pacing improves medium term but not acute cardiac adrenergic profile in congestive heart failure (2005) (0)
OS 19-01 BLOOD PRESSURE INDEPENDENT EFFECTS OF RENAL DENERVATION ON THE DECLINE OF KIDNEY FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2016) (0)
Response: Neural Sympathetic Activity in Essential Hypertension (2004) (0)
Rebuttal from Esler, Lambert, and Schlaich. (2010) (0)
Fine tuning renal denervation. (2018) (0)
submaximal exercise in young and old subjects Norepinephrine spillover at rest and during (2015) (0)
Comparative effects of T- and L- type calcium channel blockage on autonomic function in patients with mild-moderate hypertension (1999) (0)
Biochemical investigation of autonomic function—measurement of catecholamines and metabolites, and the use of spillover and allied techniques to determine regional sympathetic activation (2013) (0)
Effects of intravenous B-type natriuretic peptide (BNP) on regional sympathetic tone in patients with chronic heart failure and healthy controls (2000) (0)
Reply. (2018) (0)
Atrial ﬁbrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure (2005) (0)
Response to more research is needed to investigate the effect of denervation on blood pressure. (2014) (0)
Left atrial reduction: the forgotten (1998) (0)
Acknowledgment to Reviewers (2020) (0)
Major pulmonary contribution to desipramine-induced changes in whole body noradrenaline and adrenaline kinetics in newborn lambs (1997) (0)
Abstract 14741: Ambulatory Arterial Stiffness Index Predicts Responder of Renal Denervation (2016) (0)
Sympathetic nerve activity and left ventricular hypertrophy in human hypertension (2007) (0)
385 EFFECT OF RENAL NERVE ABLATION ON ARTERIAL STIFFNESS IN RESISTANT HYPERTENSION (2012) (0)
Harnessing the Autonomic System for Therapeutic Intervention (2014) (0)
Hypertension 1 New drugs, procedures, and devices for hypertension (2012) (0)
Predictors of Blood Pressure Response Following Catheter Renal Denervation: A Pooled Analysis of the Symplicity HTN-1 and HTN-2 Trials (2013) (0)
Workshop : epidemiology and classification of hypertension (1991) (0)
Workshop Epidemiology and Classification of Hypertension: Participants (1991) (0)
Contribution of lungs to desipramine-induced changes in whole body catecholamine kinetics in newborn lambs. (1999) (0)
ACE2 DOES NOT PLAY A MAJOR ROLE IN ANGIOTENSIN PEPTIDE METABOLISM IN THE HUMAN CORONARY CIRCULATIO: 6C.1 (2004) (0)
Cardiac Psychology: Ancient and Modern History (2015) (0)
MO085: 10-Year Clinical Events Avoided in Diabetic and Chronic Kidney Disease Hypertension Patients Treated With Radiofrequency Renal Denervation: Projections Based on 3-Year Data From the Global Symplicity Registry (2022) (0)
Controlling Blood Pressure without Drugs - Developing New Strategies Hypertension (2010) (0)
contributor to systemic hypertension sympathetic nervous system is the dominant Last Word on Point: Chronic activation of the (2015) (0)
Increased catecholamine spillover accounts for elevated circulating norodrenaline and adrenaline levels (1998) (0)
THE OVERLAPPING MECHANISM OF WEIGHT LOSS RESISTANCE AND REBOUND FROM A SIGNIFICANT WEIGHT LOSS IN OBESE SUBJECTS: P1.240 (2004) (0)
788 PROFOUND REDUCTION IN SYMPATEHTIC NERVE FIRING PATTERN AFTER RENAL DENERVATION IN RESISTANT HYPERTENSION (2012) (0)
Baroreflex sensitivity: a reliable predictor of response to renal denervation? (2014) (0)
Gender differences in added benefit of catheter-based renal denervation for resistant hypertension: model-based estimation of unadjusted and quality-adjusted life year gains in males and females (2013) (0)
Estimated Added Benefit Of Catheter-Based Renal Denervation For Moderate Treatment-Resistant Hypertension: Impact Of Age And Cardiovascular Risk Factors. (2014) (0)
Evidence for the role of peripheral α-2 receptors in reducing noradrenaline release (2000) (0)
Results from Symplicity HTN-2 (2010) (0)
ISH NIA OS-01 THE microRNA miR-19a-3p BINDS TO A POLYMORPHISM IN THE GENE FOR THE NORADRENALINE TRANSPORTER AND MAY INCREASE THE RISK OF CARDIOVASCULAR AND PSYCHIATRIC DISEASE. (2016) (0)
PP.12.09: NEURAL BIOLOGY OF PURE AUTONOMIC FAILURE (2015) (0)
Acute Electrophysiologic Effects of Intravenous Amiodarone Are Independent of a Sympatholytic Action in Humans (2003) (0)
Renal Denervation Prevents Progression of Hypertension by Reversing Baroreflex Resetting in a Rabbit Model of Chronic Kidney Disease (2017) (0)
[OP.7D.10] THE EFFECT OF RENAL DENERVATION ON ADIPOKINES IN PATIENTS WITH RESISTANT HYPERTENSION (2016) (0)
Sympathetic Nerve Protein Analysis: A Novel Window into Sympathetic Nervous System Dysfunction (2010) (0)
Pharmacological Treatments for Obesity (2010) (0)
Letters to the Editor will be published, if suitable, as space permits. They should not exceed 1000 words (typed double-spaced) in length and may be subject to editing or abridgment. (2013) (0)
The synergistic relationship between atrial fibrillation and heart failure (2002) (0)
Marked suppression of the tissue kallikrein-kinin-system in cardiac failure (2000) (0)
EVIDENCE FOR REDUCED MYOCARDIAL SYMPATHETIC INNERVATION IN HUMAN ESSENTIAL HYPERTENSION: 3C.2 (2004) (0)
Panic Disorder: Epigenetic Silencing of the Noradrenaline Transporter (NET) Gene Contributes Both to Causation and to Heart Risk (2007) (0)
Sympatho-Modulation by Renal Denervation in Spontaneously Hypertensive Rats (2013) (0)
Differential effects of T- & L-type calcium channel blockade on autonomic function in patients with mild-moderate essential hypertension (2000) (0)
Assessing the Assessment of Brain Serotonin Turnover. Authors' reply (2008) (0)
0754 International Session Role of Calcium in Energy Depletion-Induced Norepinephrine(NE)Release-Studies on Perfused Heart and Incubated Synaptosome (1996) (0)
A SELECTIVE UPREGULATION OF GABAA RECEPTOR SUBUNIT EXPRESSION IS ASSOCIATED WITH THE HYPOTENSIVE EFFECTS OF GANAXOLONE IN MALE HYPERTENSIVE SCHLAGER MICE (2021) (0)
Device-based approaches to target renal sympathetic nerves for hypertension (2016) (0)
Effects of continuous positive airway pressure (CPAP) on haemodynamics and sympathetic nervous activity in heart failure (2000) (0)
Schlaich, M. P. (2019). Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of- (2019) (0)
CENTRAL NERVOUS SYSTEM MONOAMINE NEUROTRANSMITTER HYPERTENSION TURNOVER IN PRIMARY AND OBESITY-RELATED HUMAN (1997) (0)
Abstract 3559: {beta}2-adrenoceptor Protein Expression Is Different Between Buffy Coat And Adipose Tissue (2007) (0)
Central and Peripheral Norepinephrine Secretion in Major Depression is Activated, as Assessed by 24 hour CSF and Plasma Sampling (2014) (0)
Dissociation between changes in whole body noradrenaline and adrenaline spillovers at birth in hypoxaemic fetal lambs (1998) (0)
Role of the Sympathetic Nervous System in Cardiovascular Disease (2016) (0)
In conclusion, total norepinephrine spillover data must be interpreted very cautiously. (1988) (0)
Esler and Michael Böhm MurrayC (2011) (0)
60 Release of adrenaline by human sympathetic nerves: studies in healthy subjects and patients with essential hypertension (1993) (0)
CATHETER-BASED RENAL DENERVATION – LONG TERM SAFETY AND BLOOD PRESSURE REDUCTION IN PATIENTS WITH RESISTANT HYPERTENSION (2022) (0)
OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION. (2016) (0)
1088 A SHORT HISTORY OF THE SYMPATHETIC NERVOUS SYSTEM: FROM THOMAS WILLIS TO RADIOFREQUENCY ABLATION OF THE RENAL SYMPATHETIC NERVES IN HYPERTENSION (2012) (0)
Renal Denervation for Refractory Hypertension (2011) (0)
RENAL DENERVATION REDUCES CENTRAL SYMPATHETIC DRIVE AND IMPROVES INSULIN SENSITIVITY IN PCOS: PP.26.311 (2011) (0)
Should an Alerting Response and Blood Pressure Measurement Never Be Mixed? (2021) (0)
TCT-731 TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) REDUCES SYMPATHETIC ACTIVITY AND NORMALIZES ARTERIAL SPONTANEOUS BAROREFLEX IN PATIENTS WITH AORTIC STENOSIS (2013) (0)
Is “cardiovascular protection” by estrogens due to inhibition of the sympathetic nervous system? (2005) (0)
Arterial hypertension. Pathogenesis, diagnosis and therapy (1984) (0)
2. Renal denervation in 2014: “Has a beautiful idea been ruined by cold, hard facts?” (2014) (0)
EFFECTOFPROPRANOLOL ON NORADRENALINEKINETICS INPATIENTSWITHESSENTIALHYPERTENSION (1981) (0)
Percutaneous renal sympathetic denervation for treatment of resistant hypertension (2009) (0)
PM256 Effects of Catheter-based Renal Sympathetic Denervation on Blood Pressure Variability and Morning Surge of BP in Resistant Hypertensive Patients (2014) (0)
CRT-600.06 Cost-Effectiveness of Catheter-Based Radiofrequency Renal Denervation for the Treatment of Uncontrolled Hypertension: An Analysis for the UK Based on Recent Clinical Evidence (2023) (0)
B-type natriuretic peptide (BNP), but not atrial natriuretic peptide (ANP), improves haemodynamics in acute heart failure (2000) (0)
Comparison of Patients With Congestive Heart Failure and Normal Subjects (2005) (0)
THE EFFECT OF CENTRAL LEPTIN ADMINISTRATION ON CARDIOVASCULAR RESPONSES IN CONSCIOUS RABBITS FED A HIGH-FAT DIET: 8B.3 (2004) (0)
Total body catecholamine kinetics before and after birth in spontaneously hypoxemic fetal lambs. (1999) (0)
CARDIORESPIRATORY RESPONSE TO EXERCISE AFTER RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION: 4A.10 (2011) (0)
Letter to the Editor: RE: Impaired Cardiac Baroreflex Sensitivity Predicts Responses to Renal Sympathetic Denervation in Patients with Resistant Hypertension (2014) (0)
Simultaneous characterization of sympathetic and cardiac arms of the baroreflex during incremental head-up tilt (2017) (0)
Hypotensive Effects of Ganaxolone are Associated with an Upregulation of GABAA Receptor Subunit Expression in Male Hypertensive Schlager Mice (2020) (0)
The effects of low dose clonidine on cardiac and renal sympathetic activity and brain monoamine turnover in human heart failure (2003) (0)
RESTING CARDIAC PRODUCTION OF NATRIURETIC PEPTIDES DETERMINES THE HAEMODYNAMIC EFFECTS OF BRAIN NATRIURETIC PEPTIDE IN HEART FAILURE: 6C.4 (2000) (0)
Renal sympathetic denervation for resistant hypertension – Authors' reply (2009) (0)
The Effect of Renal Nerve Ablation on Blood Pressure and Sympathetic Activity One Year Post Procedure (2013) (0)
1 st Joint Meeting of the International Society for Autonomic Neuroscience and the American Autonomic Society (2011) (0)
Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension (2023) (0)
Wednesday, May 19, Broadway Ballroom North, 10:00 AM to 12:30 PM: “I1, imidazoline receptors: Clinical relevance in hypertensive patients” (1999) (0)
European Society of Hypertens ion Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions (2009) (0)
[OP.7A.08] A POLYMORPHISM IN THE NORADRENALINE TRANSPORTER GENE IS ASSOCIATED WITH INCREASED BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION (2017) (0)
norepinephrineof voluntary exercise on hypothalamic (2015) (0)
BETA1 (ARG389GLY, SER49GLY)- AND BETA2 (ARG16GLY)-ADRENOCEPTOR POLYMORPHISMS ARE RELATED TO LEFT VENTRICULAR HYPERTROPHY USING ECG IN MIDDLE-AGED, NORMOTENSIVE SUBJECTS: PP.22.358 (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Murray David Esler?

Murray David Esler is affiliated with the following schools:

Ohio State University
University of Melbourne
University of Michigan
University of Colorado
Deakin University
University of Iowa
Massachusetts General Hospital
Monash University

Murray David Esler's Academic­Influence.com Rankings

Why Is Murray David Esler Influential?

Murray David Esler's Published Works

Published Works

What Schools Are Affiliated With Murray David Esler?

Murray David Esler's AcademicInfluence.com Rankings